TY - JOUR
T1 - Roles for endothelin receptor B and BCL2A1 in spontaneous CNS metastasis of melanoma
AU - Cruz-Muñoz, William
AU - Jaramillo, Maria L.
AU - Man, Shan
AU - Xu, Ping
AU - Banville, Myriam
AU - Collins, Catherine
AU - Nantel, Andre
AU - Francia, Giulio
AU - Morgan, Sherif S.
AU - Cranmer, Lee D.
AU - O'Connor-McCourt, Maureen D.
AU - Kerbel, Robert S.
PY - 2012/10/1
Y1 - 2012/10/1
N2 - Metastatic spread of melanoma to the central nervous system (CNS) is a common and devastating manifestation of disease progression, which, despite its clinical importance, remains poorly understood with respect to underlying molecular mechanisms. Using a recently developed preclinical model of spontaneous melanoma CNS metastasis, we have identified alterations in expression of endothelin receptor B (EDNRB ) as a potential factor that influences brain metastatic potential. Induced overexpression of this gene mediated enhanced overall metastatic disease, and resulted in an increased incidence of spontaneous CNS metastases. In contrast, the overexpression of other highlighted genes, such as BCL2A1, did not affect the incidence of CNS metastases but nevertheless appears to facilitate intracranial tumor growth. The prometastatic effect in the CNS associated with EDNRB appears to be mediated by the interaction with its ligands resulting in enhanced tumor cell proliferation and thus intracranial melanoma growth. That EDNRB contributes to melanoma metastasis is underscored by the fact that its therapeutic inhibition by the EDNRB-specific inhibitor A192621 translated into improved outcomes when treating mice with either visceral metastases or intracranial tumors. The identification of an influential role of EDNRB in CNS melanoma spontaneous metastasis may provide both a target for therapeutic intervention as well as a potential prognostic marker for patients having an increased predisposition for incidence of CNS melanoma metastases.
AB - Metastatic spread of melanoma to the central nervous system (CNS) is a common and devastating manifestation of disease progression, which, despite its clinical importance, remains poorly understood with respect to underlying molecular mechanisms. Using a recently developed preclinical model of spontaneous melanoma CNS metastasis, we have identified alterations in expression of endothelin receptor B (EDNRB ) as a potential factor that influences brain metastatic potential. Induced overexpression of this gene mediated enhanced overall metastatic disease, and resulted in an increased incidence of spontaneous CNS metastases. In contrast, the overexpression of other highlighted genes, such as BCL2A1, did not affect the incidence of CNS metastases but nevertheless appears to facilitate intracranial tumor growth. The prometastatic effect in the CNS associated with EDNRB appears to be mediated by the interaction with its ligands resulting in enhanced tumor cell proliferation and thus intracranial melanoma growth. That EDNRB contributes to melanoma metastasis is underscored by the fact that its therapeutic inhibition by the EDNRB-specific inhibitor A192621 translated into improved outcomes when treating mice with either visceral metastases or intracranial tumors. The identification of an influential role of EDNRB in CNS melanoma spontaneous metastasis may provide both a target for therapeutic intervention as well as a potential prognostic marker for patients having an increased predisposition for incidence of CNS melanoma metastases.
UR - http://www.scopus.com/inward/record.url?scp=84867125382&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84867125382&partnerID=8YFLogxK
U2 - 10.1158/0008-5472.CAN-12-2194
DO - 10.1158/0008-5472.CAN-12-2194
M3 - Article
C2 - 22865454
AN - SCOPUS:84867125382
SN - 0008-5472
VL - 72
SP - 4909
EP - 4919
JO - Cancer Research
JF - Cancer Research
IS - 19
ER -